Deep vein thrombosis after total knee replacement
Research article published in Annals of the Academy of Medicine, Singapore (2000)
Abstract
INTRODUCTION: The prevalence of deep vein thrombosis after total knee replacement has been quoted to be between 46% and 84% in the Western literature. The aims of this study were to determine its prevalence in the Singapore population and to assess the need for prophylaxis against deep vein thrombosis. MATERIALS AND METHODS: We examined data on 100 consecutive patients undergoing total knee replacement at the Adult Reconstructive Service, Department of Orthopaedic Surgery, Singapore General Hospital and assessed the possible risk factors: age, sex, weight, previous surgery, unilateral or bilateral surgery, postoperative rehabilitation, tourniquet and operating time. Functional and knee scores based on the Knee Society Clinical Rating System were also assessed. No prophylaxis was given to these patients. These patients underwent a duplex scan of both lower limbs on the seventh postoperative day. Treatment was instituted only if proximal deep vein thrombosis was detected. RESULTS: The overall incidence of deep vein thrombosis was 14% with 64.3% of it occurring distally. Deep vein thrombosis was more common in bilateral total knee replacement (22.2%) compared to unilateral total knee replacement (13.2%). Partial thrombosis was present in 71.4% and occurred predominantly in the ipsilateral leg. There was no evidence of propagation. Only 1 patient developed pulmonary embolism and was treated successfully but there was no evidence of deep vein thrombosis on duplex scan in this patient. CONCLUSION: There was no significant difference in the risk factors between patients who did and those who did not develop deep vein thrombosis.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Resumen
Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.
Por qué esto importa para la hirudoterapia
Esta cohorte prospectiva de 100 pacientes consecutivos sometidos a reemplazo total de rodilla en Singapur, que no recibieron profilaxis y fueron evaluados mediante ecografía dúplex en el día 7, encontró una incidencia general de trombosis venosa profunda del 14% (en su mayoría distal, con un embolismo pulmonar), sustancialmente inferior a las cifras del 46-84% citadas en la literatura occidental, y no identificó ningún factor de riesgo que distinguiera significativamente a quienes desarrollaron DVT. Para la hirudoterapia, el vínculo es indirecto y epidemiológico: documenta la carga de tromboembolismo venoso después de una cirugía ortopédica mayor, el ámbito del problema antitrombótico que inhibidores de trombina derivados de sanguijuela como hirudin/lepirudin han sido investigados para abordar. La advertencia es importante: este estudio observacional unicéntrico evaluó la epidemiología y el cribado de la DVT, no ninguna intervención basada en sanguijuelas ni farmacológica, por lo que proporciona únicamente contexto de fondo y ninguna evidencia sobre la eficacia o seguridad de la hirudoterapia.
Citación
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Añadido a la biblioteca ASH: May 28, 2026 · Última actualización del sitio: June 18, 2026